{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:17:45Z","timestamp":1791508665112,"version":"4.3.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1032340"],"award-info":[{"award-number":["OPP1032340"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K01-AI119180"],"award-info":[{"award-number":["K01-AI119180"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The MORDOR trial in Niger, Malawi, and Tanzania found that biannual mass distribution of azithromycin to children younger than 5 years led to a 13.5% reduction in all-cause mortality (NCT02048007). To help elucidate the mechanism for mortality reduction, we report IgG responses to 11 malaria, bacterial, and protozoan pathogens using a multiplex bead assay in pre-specified substudy of 30 communities in the rural Niger placebo-controlled trial over a three-year period (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20095642 blood specimens,\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20093814 children ages 1\u201359 months). Mass azithromycin reduces\n                    <jats:italic>Campylobacter<\/jats:italic>\n                    spp. force of infection by 29% (hazard ratio = 0.71, 95% CI: 0.56, 0.89;\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.004) but serological measures show no significant differences between groups for other pathogens against a backdrop of high transmission. Results align with a recent microbiome study in the communities. Given significant sequelae of\n                    <jats:italic>Campylobacter<\/jats:italic>\n                    infection among preschool aged children, our results support an important mechanism through which biannual mass distribution of azithromycin likely reduces mortality in Niger.\n                  <\/jats:p>","DOI":"10.1038\/s41467-022-28565-5","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T06:23:53Z","timestamp":1645424633000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Effect of biannual azithromycin distribution on antibody responses to malaria, bacterial, and protozoan pathogens in Niger"],"prefix":"10.1038","volume":"13","author":[{"given":"Ahmed M.","family":"Arzika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramatou","family":"Maliki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Brook","family":"Goodhew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Rogier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9701-0990","authenticated-orcid":false,"given":"Jeffrey W.","family":"Priest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Lebas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1962-5321","authenticated-orcid":false,"given":"Kieran S.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3051-0568","authenticated-orcid":false,"given":"Victoria","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine E.","family":"Oldenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2733-8370","authenticated-orcid":false,"given":"Thuy","family":"Doan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis C.","family":"Porco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7118-1457","authenticated-orcid":false,"given":"Jeremy D.","family":"Keenan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8216-0240","authenticated-orcid":false,"given":"Thomas M.","family":"Lietman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana L.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6105-7295","authenticated-orcid":false,"given":"Benjamin F.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"MORDOR-Niger Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,21]]},"reference":[{"key":"28565_CR1","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1016\/S0140-6736(17)31758-0","volume":"390","author":"N Golding","year":"2017","unstructured":"Golding, N. et al. Mapping under-5 and neonatal mortality in Africa, 2000-15: a baseline analysis for the Sustainable Development Goals. Lancet Lond. Engl. 390, 2171\u20132182 (2017).","journal-title":"Lancet Lond. Engl."},{"key":"28565_CR2","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1056\/NEJMoa1715474","volume":"378","author":"JD Keenan","year":"2018","unstructured":"Keenan, J. D. et al. Azithromycin to reduce childhood mortality in sub-Saharan Africa. N. Engl. J. Med. 378, 1583\u20131592 (2018).","journal-title":"N. Engl. J. Med."},{"key":"28565_CR3","doi-asserted-by":"publisher","first-page":"e288","DOI":"10.1016\/S2214-109X(19)30540-6","volume":"8","author":"JD Keenan","year":"2020","unstructured":"Keenan, J. D. et al. Cause-specific mortality of children younger than 5 years in communities receiving biannual mass azithromycin treatment in Niger: verbal autopsy results from a cluster-randomised controlled trial. Lancet Glob. Health 8, e288\u2013e295 (2020).","journal-title":"Lancet Glob. Health"},{"key":"28565_CR4","doi-asserted-by":"publisher","first-page":"e1002835","DOI":"10.1371\/journal.pmed.1002835","volume":"16","author":"AM Arzika","year":"2019","unstructured":"Arzika, A. M. et al. Biannual mass azithromycin distributions and malaria parasitemia in pre-school children in Niger: a cluster-randomized, placebo-controlled trial. PLoS Med. 16, e1002835 (2019).","journal-title":"PLoS Med."},{"key":"28565_CR5","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/s41591-019-0533-0","volume":"25","author":"T Doan","year":"2019","unstructured":"Doan, T. et al. Gut microbiome alteration in MORDOR I: a community-randomized trial of mass azithromycin distribution. Nat. Med. 25, 1370\u20131376 (2019).","journal-title":"Nat. Med."},{"key":"28565_CR6","doi-asserted-by":"publisher","unstructured":"Platts-Mills, J. A. et al. Impact of biannual mass azithromycin treatment on enteropathogen carriage in children younger than 5 years in Niger. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciab1046 (2022).","DOI":"10.1093\/cid\/ciab1046"},{"key":"28565_CR7","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1056\/NEJMoa2002606","volume":"383","author":"T Doan","year":"2020","unstructured":"Doan, T. et al. Macrolide and nonmacrolide resistance with mass azithromycin distribution. N. Engl. J. Med. 383, 1941\u20131950 (2020).","journal-title":"N. Engl. J. Med."},{"key":"28565_CR8","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.3201\/eid2407.171928","volume":"24","author":"BF Arnold","year":"2018","unstructured":"Arnold, B. F., Scobie, H. M., Priest, J. W. & Lammie, P. J. Integrated serologic surveillance of population immunity and disease transmission. Emerg. Infect. Dis. 24, 1188\u20131194 (2018).","journal-title":"Emerg. Infect. Dis."},{"key":"28565_CR9","doi-asserted-by":"publisher","first-page":"e45594","DOI":"10.7554\/eLife.45594","volume":"8","author":"BF Arnold","year":"2019","unstructured":"Arnold, B. F. et al. Enteropathogen antibody dynamics and force of infection among children in low-resource settings. eLife 8, e45594 (2019).","journal-title":"eLife"},{"key":"28565_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-018-2566-0","volume":"17","author":"JW Priest","year":"2018","unstructured":"Priest, J. W. et al. Specificity of the IgG antibody response to Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae, and Plasmodium ovale MSP119 subunit proteins in multiplexed serologic assays. Malar. J. 17, 417 (2018).","journal-title":"Malar. J."},{"key":"28565_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-019-3027-0","volume":"18","author":"E Rogier","year":"2019","unstructured":"Rogier, E. et al. High-throughput malaria serosurveillance using a one-step multiplex bead assay. Malar. J. 18, 402 (2019).","journal-title":"Malar. J."},{"key":"28565_CR12","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3389\/fimmu.2020.00928","volume":"11","author":"LL van den Hoogen","year":"2020","unstructured":"van den Hoogen, L. L. et al. Selection of antibody responses associated with Plasmodium falciparum infections in the context of malaria elimination. Front. Immunol. 11, 928 (2020).","journal-title":"Front. Immunol."},{"key":"28565_CR13","doi-asserted-by":"publisher","first-page":"617951","DOI":"10.3389\/fimmu.2021.617951","volume":"12","author":"E Rogier","year":"2021","unstructured":"Rogier, E. et al. Framework for characterizing longitudinal antibody response in children after Plasmodium falciparum infection. Front. Immunol. 12, 617951 (2021).","journal-title":"Front. Immunol."},{"key":"28565_CR14","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1074\/jbc.M608615200","volume":"282","author":"ABS Sidhu","year":"2007","unstructured":"Sidhu, A. B. S. et al. In vitro efficacy, resistance selection, and structural modeling studies implicate the malarial parasite apicoplast as the target of azithromycin. J. Biol. Chem. 282, 2494\u20132504 (2007).","journal-title":"J. Biol. Chem."},{"key":"28565_CR15","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1128\/AAC.00527-07","volume":"51","author":"EL Dahl","year":"2007","unstructured":"Dahl, E. L. & Rosenthal, P. J. Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast. Antimicrob. Agents Chemother. 51, 3485\u20133490 (2007).","journal-title":"Antimicrob. Agents Chemother."},{"key":"28565_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1086\/515071","volume":"28","author":"WR Taylor","year":"1999","unstructured":"Taylor, W. R. et al. Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia. Clin. Infect. Dis. 28, 74\u201381 (1999).","journal-title":"Clin. Infect. Dis."},{"key":"28565_CR17","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.4269\/ajtmh.2005.73.1108","volume":"73","author":"MW Dunne","year":"2005","unstructured":"Dunne, M. W. et al. A double-blind, randomized study of azithromycin compared to chloroquine for the treatment of Plasmodium vivax malaria in India. Am. J. Trop. Med. Hyg. 73, 1108\u20131111 (2005).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"28565_CR18","first-page":"CD004406","volume":"9","author":"ML van Driel","year":"2016","unstructured":"van Driel, M. L., De Sutter, A. I., Habraken, H., Thorning, S. & Christiaens, T. Different antibiotic treatments for group A streptococcal pharyngitis. Cochrane Database Syst. Rev. 9, CD004406 (2016).","journal-title":"Cochrane Database Syst. Rev."},{"key":"28565_CR19","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1093\/clinids\/21.3.536","volume":"21","author":"RA Kuschner","year":"1995","unstructured":"Kuschner, R. A. et al. Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent. Clin. Infect. Dis. 21, 536\u2013541 (1995).","journal-title":"Clin. Infect. Dis."},{"key":"28565_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.7205\/MILMED-D-17-00068","volume":"182","author":"DR Tribble","year":"2017","unstructured":"Tribble, D. R. Antibiotic therapy for acute watery diarrhea and dysentery. Mil. Med. 182, 17\u201325 (2017).","journal-title":"Mil. Med."},{"key":"28565_CR21","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1056\/NEJMoa054493","volume":"354","author":"D Saha","year":"2006","unstructured":"Saha, D. et al. Single-dose azithromycin for the treatment of cholera in adults. N. Engl. J. Med. 354, 2452\u20132462 (2006).","journal-title":"N. Engl. J. Med."},{"key":"28565_CR22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S1473-3099(14)70772-8","volume":"15","author":"W Checkley","year":"2015","unstructured":"Checkley, W. et al. A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium. Lancet Infect. Dis. 15, 85\u201394 (2015).","journal-title":"Lancet Infect. Dis."},{"key":"28565_CR23","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1128\/CMR.14.1.114-128.2001","volume":"14","author":"TB Gardner","year":"2001","unstructured":"Gardner, T. B. & Hill, D. R. Treatment of giardiasis. Clin. Microbiol. Rev. 14, 114\u2013128 (2001).","journal-title":"Clin. Microbiol. Rev."},{"key":"28565_CR24","first-page":"547","volume":"4","author":"J Jeske","year":"1998","unstructured":"Jeske, J. et al. Effectiveness of azithromycin in the treatment of giardiasis. Med. Sci. Monit. 4, 547\u2013550 (1998).","journal-title":"Med. Sci. Monit."},{"key":"28565_CR25","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/infdis\/127.2.164","volume":"127","author":"NW Smith","year":"1973","unstructured":"Smith, N. W. & Sack, R. B. Immunologic cross-reactions of enterotoxins from Escherichia coli and Vibrio cholerae. J. Infect. Dis. 127, 164\u2013170 (1973).","journal-title":"J. Infect. Dis."},{"key":"28565_CR26","doi-asserted-by":"publisher","first-page":"e568","DOI":"10.1016\/S2214-109X(19)30076-2","volume":"7","author":"KL Kotloff","year":"2019","unstructured":"Kotloff, K. L. et al. The incidence, aetiology, and adverse clinical consequences of less severe diarrhoeal episodes among infants and children residing in low-income and middle-income countries: a 12-month case-control study as a follow-on to the Global Enteric Multicenter Study (GEMS). Lancet Glob. Health 7, e568\u2013e584 (2019).","journal-title":"Lancet Glob. Health"},{"key":"28565_CR27","doi-asserted-by":"publisher","first-page":"e0005616","DOI":"10.1371\/journal.pntd.0005616","volume":"11","author":"BF Arnold","year":"2017","unstructured":"Arnold, B. F. et al. Measuring changes in transmission of neglected tropical diseases, malaria, and enteric pathogens from quantitative antibody levels. PLoS Negl. Trop. Dis. 11, e0005616 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"28565_CR28","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1128\/jcm.33.11.2826-2832.1995","volume":"33","author":"A Burnens","year":"1995","unstructured":"Burnens, A., Stucki, U., Nicolet, J. & Frey, J. Identification and characterization of an immunogenic outer membrane protein of Campylobacter jejuni. J. Clin. Microbiol. 33, 2826\u20132832 (1995).","journal-title":"J. Clin. Microbiol."},{"key":"28565_CR29","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","volume":"25","author":"SF Altschul","year":"1997","unstructured":"Altschul, S. F. et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25, 3389\u20133402 (1997).","journal-title":"Nucleic Acids Res."},{"key":"28565_CR30","doi-asserted-by":"publisher","first-page":"5101","DOI":"10.1111\/j.1742-4658.2005.04945.x","volume":"272","author":"SF Altschul","year":"2005","unstructured":"Altschul, S. F. et al. Protein database searches using compositionally adjusted substitution matrices. FEBS J. 272, 5101\u20135109 (2005).","journal-title":"FEBS J."},{"key":"28565_CR31","first-page":"1171","volume":"63","author":"C Amour","year":"2016","unstructured":"Amour, C. et al. Epidemiology and impact of campylobacter infection in children in 8 low-resource settings: results from the MAL-ED study. Clin. Infect. Dis. 63, 1171\u20131179 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"28565_CR32","doi-asserted-by":"publisher","first-page":"e564","DOI":"10.1016\/S2214-109X(15)00151-5","volume":"3","author":"JA Platts-Mills","year":"2015","unstructured":"Platts-Mills, J. A. et al. Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED). Lancet Glob. Health 3, e564\u2013e575 (2015).","journal-title":"Lancet Glob. Health"},{"key":"28565_CR33","doi-asserted-by":"publisher","unstructured":"Rogawski, E. T. et al. Use of quantitative molecular diagnostic methods to investigate the effect of enteropathogen infections on linear growth in children in low-resource settings: longitudinal analysis of results from the MAL-ED cohort study. Lancet Glob. Health https:\/\/doi.org\/10.1016\/S2214-109X(18)30351-6 (2018).","DOI":"10.1016\/S2214-109X(18)30351-6"},{"key":"28565_CR34","doi-asserted-by":"publisher","unstructured":"Grembi, J. A. et al. Effect of water, sanitation, handwashing and nutrition interventions on enteropathogens in children 14 months old: a cluster-randomized controlled trial in rural Bangladesh. J. Infect. Dis. https:\/\/doi.org\/10.1093\/infdis\/jiaa549 (2020).","DOI":"10.1093\/infdis\/jiaa549"},{"key":"28565_CR35","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/infdis\/jiz179","volume":"221","author":"ET Rogawski McQuade","year":"2020","unstructured":"Rogawski McQuade, E. T. et al. Impact of water quality, sanitation, handwashing, and nutritional interventions on enteric infections in Rural Zimbabwe: The Sanitation Hygiene Infant Nutrition Efficacy (SHINE) trial. J. Infect. Dis. 221, 1379\u20131386 (2020).","journal-title":"J. Infect. Dis."},{"key":"28565_CR36","doi-asserted-by":"publisher","first-page":"e62278","DOI":"10.7554\/eLife.62278","volume":"10","author":"J Knee","year":"2021","unstructured":"Knee, J. et al. Effects of an urban sanitation intervention on childhood enteric infection and diarrhea in Maputo, Mozambique: a controlled before-and-after trial. eLife 10, e62278 (2021).","journal-title":"eLife"},{"key":"28565_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-216","volume":"14","author":"EB Goodhew","year":"2014","unstructured":"Goodhew, E. B. et al. Longitudinal analysis of antibody responses to trachoma antigens before and after mass drug administration. BMC Infect. Dis. 14, 216 (2014).","journal-title":"BMC Infect. Dis."},{"key":"28565_CR38","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/cid\/ciy973","volume":"68","author":"TC Porco","year":"2019","unstructured":"Porco, T. C. et al. Mass oral azithromycin for childhood mortality: timing of death after distribution in the MORDOR trial. Clin. Infect. Dis. 68, 2114\u20132116 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"28565_CR39","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/526182a","volume":"526","author":"R Nuzzo","year":"2015","unstructured":"Nuzzo, R. How scientists fool themselves\u2014and how they can stop. Nature 526, 182\u2013185 (2015).","journal-title":"Nature"},{"key":"28565_CR40","doi-asserted-by":"publisher","first-page":"e1873","DOI":"10.1371\/journal.pntd.0001873","volume":"6","author":"EB Goodhew","year":"2012","unstructured":"Goodhew, E. B. et al. CT694 and pgp3 as serological tools for monitoring trachoma programs. PLoS Negl. Trop. Dis. 6, e1873 (2012).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"28565_CR41","doi-asserted-by":"publisher","first-page":"e0141047","DOI":"10.1371\/journal.pone.0141047","volume":"10","author":"KE Mues","year":"2015","unstructured":"Mues, K. E. et al. Changes in antibody levels during and following an episode of acute adenolymphangitis (ADL) among lymphedema patients in L\u00e9og\u00e2ne, Haiti. PloS ONE 10, e0141047 (2015).","journal-title":"PloS ONE"},{"key":"28565_CR42","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1128\/CVI.00160-10","volume":"17","author":"JW Priest","year":"2010","unstructured":"Priest, J. W. et al. Multiplex assay detection of immunoglobulin G antibodies that recognize Giardia intestinalis and Cryptosporidium parvum antigens. Clin. Vaccin. Immunol. 17, 1695\u20131707 (2010).","journal-title":"Clin. Vaccin. Immunol."},{"key":"28565_CR43","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1056\/NEJMra012493","volume":"345","author":"RM Zinkernagel","year":"2001","unstructured":"Zinkernagel, R. M. Maternal antibodies, childhood infections, and autoimmune diseases. N. Engl. J. Med. 345, 1331\u20131335 (2001).","journal-title":"N. Engl. J. Med."},{"key":"28565_CR44","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1111\/2041-210X.12797","volume":"8","author":"MA Stoffel","year":"2017","unstructured":"Stoffel, M. A., Nakagawa, S. & Schielzeth, H. rptR: repeatability estimation and variance decomposition by generalized linear mixed-effects models. Methods Ecol. Evol. 8, 1639\u20131644 (2017).","journal-title":"Methods Ecol. Evol."},{"key":"28565_CR45","doi-asserted-by":"crossref","unstructured":"Wood, S. Generalized Additive Models: An Introduction with R. (Chapman and Hall\/CRC, 2017).","DOI":"10.1201\/9781315370279"},{"key":"28565_CR46","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/sim.2291","volume":"25","author":"Z Shkedy","year":"2006","unstructured":"Shkedy, Z., Aerts, M., Molenberghs, G., Beutels, P. & Van Damme, P. Modelling age-dependent force of infection from prevalence data using fractional polynomials. Stat. Med. 25, 1577\u20131591 (2006).","journal-title":"Stat. Med."},{"key":"28565_CR47","unstructured":"Wood, S. mgcv:Mixed GAM Computation Vehicle with GCV\/AIC\/REML Smoothness Estimation. (University of Bath, 2012)."},{"key":"28565_CR48","doi-asserted-by":"crossref","unstructured":"Ruppert, D., Wand, M. P. & Carroll, R. J. Semiparametric Regression. (Cambridge University Press, 2003).","DOI":"10.1017\/CBO9780511755453"},{"key":"28565_CR49","doi-asserted-by":"publisher","first-page":"23174","DOI":"10.1073\/pnas.2008951117","volume":"117","author":"BF Arnold","year":"2020","unstructured":"Arnold, B. F. et al. Fine-scale heterogeneity in Schistosoma mansoni force of infection measured through antibody response. Proc. Natl Acad. Sci. USA 117, 23174\u201323181 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"28565_CR50","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/esr\/jcv090","volume":"32","author":"AW Schmidt-Catran","year":"2016","unstructured":"Schmidt-Catran, A. W. & Fairbrother, M. The random effects in multilevel models: getting them wrong and getting them right. Eur. Sociol. Rev. 32, 23\u201338 (2016).","journal-title":"Eur. Sociol. Rev."},{"key":"28565_CR51","first-page":"1","volume":"61","author":"RG Miller","year":"1974","unstructured":"Miller, R. G. The jackknife\u2014a review. Biometrika 61, 1\u201315 (1974).","journal-title":"Biometrika"},{"key":"28565_CR52","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMc1901535","volume":"380","author":"T Doan","year":"2019","unstructured":"Doan, T. et al. Macrolide resistance in MORDOR I\u2014a cluster-randomized trial in niger. N. Engl. J. Med. 380, 2271\u20132273 (2019).","journal-title":"N. Engl. J. Med."},{"key":"28565_CR53","unstructured":"Hayes, R. J. & Moulton, L. H. Cluster Randomised Trials. (Taylor & Francis Group, 2017)."},{"key":"28565_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-019-3033-2","volume":"18","author":"CE Oldenburg","year":"2019","unstructured":"Oldenburg, C. E. et al. Biannual versus annual mass azithromycin distribution and malaria seroepidemiology among preschool children in Niger: a sub-study of a cluster randomized trial. Malar. J. 18, 389 (2019).","journal-title":"Malar. J."},{"key":"28565_CR55","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B Methodol. 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. Ser. B Methodol."},{"key":"28565_CR56","doi-asserted-by":"publisher","unstructured":"Arnold, B. et al. Multiplex IgG antibody response and malaria parasitemia among children ages 1\u201359 months in the MORDOR Niger trial, 2015\u20132018. https:\/\/doi.org\/10.7272\/Q6VX0DSD (2021).","DOI":"10.7272\/Q6VX0DSD"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28565-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28565-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28565-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T18:53:13Z","timestamp":1726685593000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28565-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,21]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["28565"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-28565-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.04.23.21255957","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,21]]},"assertion":[{"value":"30 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests. The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Use of trade names is for identification only and does not imply endorsement by the Public Health Service or by the U.S. Department of Health and Human Services.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"976"}}